Insulatard HM SC Injection

Introduction

Insulatard HM SC Injection 40 IU/ml is a synthetic form of insulin used to manage blood glucose levels in people with diabetes. It is designed to mimic the natural insulin produced by the pancreas over an extended period, providing a stable and prolonged control of blood sugar levels.

Uses

Long-acting insulin is primarily used for:

Managing blood glucose levels in individuals with type 1 diabetes.
Managing blood glucose levels in individuals with type 2 diabetes who require insulin therapy.
Providing basal insulin coverage to help maintain consistent blood glucose levels throughout the day and night.

Brand Name	Insulatard HM
Type	SC Injection
Weight	40 IU/ml
Generic	Insulin Human [Long-Acting]
Manufacturer	Novo Nordisk (Mfg. by: Eskayef Pharmaceuticals Ltd.)
Available in	English বাংলা

Mechanism of Action

Long-acting insulin works by stimulating the uptake of glucose into cells, particularly muscle and fat cells, and inhibiting glucose production in the liver. It binds to insulin receptors on cell membranes, promoting glucose transport and utilization, which helps to lower blood glucose levels.

How Long Does It Take to Work?

The onset of action for long-acting insulin typically occurs within 1 to 2 hours after administration. The full therapeutic effect may take several hours to establish, and it provides a steady release of insulin over a period of 24 hours or more, depending on the specific formulation used.

Absorption

Long-acting insulin is absorbed slowly from the subcutaneous tissue into the bloodstream. The rate of absorption can be influenced by factors such as injection site, blood flow, and body temperature.

Route of Elimination

Insulin is metabolized primarily in the liver and kidneys. It is broken down by insulinase and other proteolytic enzymes. The metabolites are then excreted through urine.

Dosage

Dosage of long-acting insulin varies based on individual needs and blood glucose levels. Typical starting doses may range from 10 to 20 units daily, adjusted as necessary based on blood glucose monitoring. Dosage should be individualized based on the patient’s insulin sensitivity, dietary intake, and activity levels.

Administration

Long-acting insulin is administered via subcutaneous injection. Common injection sites include the abdomen, thighs, and buttocks. It is typically given once or twice daily, depending on the specific formulation and patient needs. Always follow the specific dosing instructions provided by a healthcare provider.

Side Effects

Common side effects include:

Hypoglycemia (low blood sugar).
Injection site reactions such as pain, redness, or swelling.
Weight gain.
Allergic reactions.

Rare but serious side effects may include:

Severe hypoglycemia, which can lead to confusion, seizures, or loss of consciousness.
Insulin resistance.

Toxicity

Excessive dosing of long-acting insulin can lead to severe hypoglycemia, characterized by symptoms such as sweating, trembling, dizziness, and confusion. Severe cases may require medical intervention, including glucose administration or glucagon injection.

Precautions

Precautions include:

Regular monitoring of blood glucose levels to adjust dosing as needed.
Proper storage and handling of insulin to maintain efficacy.
Awareness of symptoms of hypoglycemia and hyperglycemia.
Avoiding abrupt changes in diet or physical activity without adjusting insulin dosages accordingly.

Interaction

Long-acting insulin can interact with various medications, including:

Oral hypoglycemic agents, which may require dosage adjustments.
Certain antihypertensives or diuretics, which may affect glucose levels.
Beta-blockers, which may mask symptoms of hypoglycemia.

Disease Interaction

Use with caution in individuals with:

Kidney or liver disease, which may affect insulin metabolism and clearance.
Conditions that may affect glucose metabolism, such as thyroid disorders or adrenal insufficiency.

Drug Interaction

Drug interactions may occur with:

Medications that alter glucose metabolism, including corticosteroids and some antipsychotics.
Drugs that affect insulin absorption or action, such as certain antiretrovirals.

Food Interactions

There are no specific food interactions, but maintaining a consistent diet helps in managing blood glucose levels effectively. Be aware of changes in diet that may require adjustments in insulin dosage.

Pregnancy Use

Long-acting insulin is generally considered safe during pregnancy. However, blood glucose levels need to be carefully monitored, and insulin doses may need to be adjusted based on changes in insulin requirements during pregnancy.

Lactation Use

Insulin use is generally considered safe during lactation. Insulin does not pass into breast milk in significant amounts, but blood glucose levels should be monitored closely to ensure proper management.

Acute Overdose

Acute overdose of long-acting insulin can result in severe hypoglycemia. Symptoms include sweating, confusion, dizziness, and loss of consciousness. Immediate treatment with oral glucose or intravenous glucose, or glucagon injection, may be required.

Contraindication

Long-acting insulin should be avoided in individuals with:

Severe hypersensitivity or allergic reactions to insulin.
Uncontrolled hypoglycemia or significant insulin resistance.

Use Direction

Follow the instructions provided by the healthcare provider or manufacturer for dosage and administration. Regular monitoring of blood glucose levels is essential for adjusting insulin dosages and maintaining optimal control.

Storage Conditions

Store insulin in the refrigerator between 2°C and 8°C (36°F and 46°F). Do not freeze. Once in use, insulin may be stored at room temperature for up to 28 days, depending on the specific product. Protect from light and heat.

Volume of Distribution

The volume of distribution of long-acting insulin is not specifically documented. It is distributed throughout the extracellular fluid and binds to insulin receptors on target cells.

Half Life

The half-life of long-acting insulin can vary depending on the formulation. For example, insulin glargine has a half-life of approximately 12 to 19 hours. The duration of action extends beyond the half-life due to its formulation designed for prolonged release.

Clearance

Long-acting insulin is primarily cleared through hepatic and renal metabolism. The clearance rate may be influenced by factors such as liver or kidney function, as well as concurrent medications.

See in details version Insulatard HM SC Injection 40 IU/ml also Insulatard HM SC Injection 40 IU/ml in bangla